Navigation Links
Isis Reports Financial Results and Highlights for Fiscal year 2007
Date:3/13/2008

by Isis and Isis' partners, the Company anticipates many clinical events for 2008; some are highlighted below:
* Isis' cardiovascular franchise will continue to provide clinical

evidence to support the activity and safety profiles of

second-generation antisense drugs. Isis completed two key goals

early, including the licensing of mipomersen, the lead drug in this

franchise, to Genzyme and the initiation of Phase 3 studies of

mipomersen in patients with Familial Hypercholesterolemia.

* Over the upcoming months, Isis expects to effect a seamless

transition of mipomersen development to Genzyme.

* Isis and Genzyme expect to report new safety data for

mipomersen.

* Isis expects to initiate Phase 1 clinical studies of ISIS

353512 that targets CRP for the treatment of coronary artery

disease.

* Isis and BMS expect to advance into development a drug

targeting PCSK9 for the treatment of cardiovascular disease.

* Isis' metabolic franchise, which consists of four novel and

complementary drugs to treat type 2 diabetes, will continue to grow,

with clinical data expected from the most advanced of the four drugs,

ISIS 113715, and Isis will continue to explore the therapeutic

opportunities for antisense drugs to treat obesity.

* Isis expects to report Phase 2 study data in Type 2 diabetics

treated with ISIS 113715 and sulfonylureas.

* Isis expects to complete the Phase 1 study of ISIS 325568, an

antisense drug licensed to OMI that targets GCGR to treat

diabetes. Isis expects OMI will choose to initiate Phase 2

studies of ISIS 325568 in patients with type 2 diabetes.

* Isis' partners developing antisense drugs
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... McMaster scientists have found that an anticonvulsant drug may ... , Although dozens of antibiotics target what bacteria do, ... of bacteria are created, and they found there is ... is important as there is growing concern worldwide about ... ineffective. The World Health Organization has declared that antibiotic ...
(Date:9/22/2014)... US (PRWEB) September 22, 2014 This ... perspectives on stakeholder management needs for the Prostate Cancer ... Heartbeat Experts on stakeholder strategies for any launching Prostate ... points of differentiation within an increasingly crowded market , ... The impact of identifying community-based thought leaders and ...
(Date:9/22/2014)... Kessler researchers have published a pilot study showing ... in people with multiple sclerosis (MS). Improvements ... stress, and pain. "Development and effectiveness of ... MS: Description and outcomes" was epublished ahead of ... Journal of MS Care (doi: 10.7224/1537-2073.2013-045). The ...
(Date:9/22/2014)... New York, New York (PRWEB) September 22, 2014 ... risks associated with the use of power morcellators ... Liebhard LLP notes a new report detailing the ... despite warnings from federal regulators that specifically discouraged ... these physicians believe that the potential cancer risks ...
(Date:9/22/2014)... Barbara Bronson Gray HealthDay Reporter ... every pregnant woman wonders: What can I do to help ... iron supplements as prescribed may play a role in reducing ... (ASD). The researchers found that mothers of children with ... before and during pregnancy than those whose children seem to ...
Breaking Medicine News(10 mins):Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3
... announced today that ALIGN(R) is now available through ... builds and maintains a natural defense against ... as constipation, diarrhea, abdominal discomfort, urgency, gas and ... contains Bifantis(R) (Bifidobacterium infantis 35624), a natural probiotic ...
... the demand for healthcare services set to more ... years, the Indian healthcare industry appears ripe for ... healthcare budgets have attracted big ticket foreign ... clinical trials, medical devices and equipment, healthcare services, ...
... that will be presented at the annual meeting of ... (July 7-11, 2007), scientists implemented a successful bioeradication ... Victoria. , Two insect biocontrol species, weevils ... removal, to control the highly invasive water hyacinth, which ...
... demonstrated conclusively that a specific protein and its signaling ... essential to the creation and repair of the brains ... mouse models points the way to developing treatments or ... repair in children and adults. The paper will be ...
... in the Pennsylvania government after a deal was struck between ... 24,000 state workers returned to work after they were sent ... all sides can say that they achieved some of their ... declaring himself "very satisfied with where we came out." ...
... to consider a radical change in their lifestyles, if ... a report prepared by the Centre for Alternative Technology ... report, the lifestyle changes could include having vegetarian meals, ... ,Paul Allen, CAT's Development Director, was quoted ...
Cached Medicine News:Health News:Government Policies and Booming Economy Keep Indian Healthcare in Top Shape 2Health News:Government Policies and Booming Economy Keep Indian Healthcare in Top Shape 3Health News:Water Hyacinth is Used for Health Improvements in Africa 2Health News:Water Hyacinth is Used for Health Improvements in Africa 3Health News:Water Hyacinth is Used for Health Improvements in Africa 4Health News:Specific Protein is Instrumental in Myelination 2Health News:Specific Protein is Instrumental in Myelination 3Health News:Pennsylvania Government's Partial Shutdown Ends 2Health News:Radical Change in the Lifestyle Might Bring a Greener Future for Brits 2
(Date:9/22/2014)... , Sept. 22, 2014 ... the U.S. commercial launch of its foot plating system ... Paragon 28.  The GORILLA TM R3CON PLATING SYSTEM ... the Monster TM & Mini-Monster TM Screw ... Comprised of 10 interchangeable subsystems, the GORILLA TM ...
(Date:9/22/2014)... Sept. 22, 2014 The western European ... It is largely a replacement market with fewer ... mergers, acquisitions and partnerships are redefining competitive landscape ... research service provides details about revenue forecasts, unit ... trends across the country. The changing landscape makes ...
(Date:9/22/2014)... 2014 ... the addition of the  "Global Freeze Drying ... Market - Forecast to 2019"  report to ... ,The global freeze drying market was valued ... expected to reach at $2,655.9 million by ...
Breaking Medicine Technology:Paragon 28, Inc. Launches the GORILLA(TM) R3CON PLATING SYSTEM 2Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3
... 4, 2011 Reportlinker.com announces that a new market ... Personalized Medicine - scientific & commercial aspects ... aim of personalized medicine or individualized treatment is to ... in some cases, even to design the appropriate treatment ...
... a proposed Settlement in a class action lawsuit involving ... treat a variety of medical conditions including: cancer, HIV, ... blood issues, and many other conditions.  These drugs are ... This lawsuit is not about whether these drugs ...
Cached Medicine Technology:Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 2Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 3Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects 4Medicare Part B Subscribers Who Made a Percentage Co-Payment for Certain Drugs May Be Able To Get a Refund from a Class Action Settlement 2
... is a complete practice and business ... optometrists, opticians and ophthalmologists- It is ... seeking a graphically rich and intuitive ... of solid features and functionality- The ...
... 70 hematology system delivers a ... Designed for speed and accuracy, ... cost-effectiveness with impressive productivity. The ... on its own or twinned ...
The SE-9500 automated hematology analyzerprovides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
Medicine Products: